Qu Feng, Li Chun-Bao, Yuan Bang-Tuo, Qi Wei, Li Hong-Liang, Shen Xue-Zhen, Zhao Gang, Wang Jiang-Tao, Liu Yu-Jie
Department of Orthopedics, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, P.R. China; Department of Orthopedics, Chinese People's Liberation Army General Hospital, Beijing 100853, P.R. China.
Department of Orthopedics, Chinese People's Liberation Army General Hospital, Beijing 100853, P.R. China.
Oncol Lett. 2016 Feb;11(2):1592-1596. doi: 10.3892/ol.2015.4073. Epub 2015 Dec 31.
MicroRNAs (miRNAs/miRs) are a type of highly conserved, small non-coding RNA that are vital to the post-transcriptional regulation of gene expression via base pairing with target mRNA 3'-untranslated regions (3'-UTRs). Several studies have indicated that the abnormal expression of miRNAs occurs frequently in human osteosarcoma (OS). In the present study, the role of miR-26a in the progression and metastasis of OS was investigated using reverse transcription-quantitative polymerase chain reaction, a luciferase activity assay, cell viability assay, migration and invasion assays, transfection and western blot analysis. miR-26a was upregulated in OS tissues and cell lines, and the expression of miR-26a was indicated to affect the proliferation, migration and invasion of OS Saos-2 cells. At the molecular level, the results showed that glycogen synthase kinase-3β (GSK-3β) was identified as a target of miR-26a, and the ectopic expression of miR-26a inhibited GSK-3β by directly binding to the 3'-UTR. Therefore, the expression of miR-26a was negatively correlated with GSK-3β in the OS tissues. These data suggest that miR-26a is significant in the proliferation of human OS cells due to the direct regulation of Wnt/β-catenin signaling.
微小RNA(miRNA/miR)是一类高度保守的小型非编码RNA,通过与靶mRNA的3'-非翻译区(3'-UTR)碱基配对,对基因表达的转录后调控至关重要。多项研究表明,miRNA的异常表达在人类骨肉瘤(OS)中频繁发生。在本研究中,采用逆转录定量聚合酶链反应、荧光素酶活性测定、细胞活力测定、迁移和侵袭测定、转染及蛋白质免疫印迹分析,研究了miR-26a在骨肉瘤进展和转移中的作用。miR-26a在骨肉瘤组织和细胞系中上调,且miR-26a的表达影响骨肉瘤Saos-2细胞的增殖、迁移和侵袭。在分子水平上,结果表明糖原合酶激酶-3β(GSK-3β)被确定为miR-26a的靶标,miR-26a的异位表达通过直接结合3'-UTR抑制GSK-3β。因此,在骨肉瘤组织中,miR-26a的表达与GSK-3β呈负相关。这些数据表明,miR-26a通过直接调控Wnt/β-连环蛋白信号通路,在人类骨肉瘤细胞增殖中具有重要作用。